US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 9.010
  • -0.330-3.53%
Close Nov 25 16:00 ET
  • 8.900
  • -0.110-1.22%
Post 19:58 ET
190.91MMarket Cap-1653P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enanta Pharmaceuticals Q4 2024 Estimates Date

Currency：USDNov 25, 2024

Estimate YoY
Revenue
17.83M
-5.83%
EPS
-1.07
+19.33%
Analyst Rating
Strong Buy

Nov 7, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.233M--
--2025/Q1-- / 18.899M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.233M--
--2025/Q1-- / 18.899M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

  • Enanta Pharmaceuticals | 8-K: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024

    16:09 ET

  • Enanta Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Aug 7 16:02 ET

  • Enanta Pharmaceuticals | 8-K: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter

    Aug 5 16:08 ET

  • Enanta Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    May 8 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data